These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


370 related items for PubMed ID: 20709527

  • 1. Carbonic anhydrase 9 in clear cell renal cell carcinoma: a marker for diagnosis, prognosis and treatment.
    Tostain J, Li G, Gentil-Perret A, Gigante M.
    Eur J Cancer; 2010 Dec; 46(18):3141-8. PubMed ID: 20709527
    [Abstract] [Full Text] [Related]

  • 2. CA9 as a molecular marker for differential diagnosis of cystic renal tumors.
    Li G, Bilal I, Gentil-Perret A, Feng G, Zhao A, Peoc'h M, Genin C, Tostain J, Gigante M.
    Urol Oncol; 2012 Dec; 30(4):463-8. PubMed ID: 20822935
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Carbonic anhydrase IX in renal cell carcinoma: implications for prognosis, diagnosis, and therapy.
    Stillebroer AB, Mulders PF, Boerman OC, Oyen WJ, Oosterwijk E.
    Eur Urol; 2010 Jul; 58(1):75-83. PubMed ID: 20359812
    [Abstract] [Full Text] [Related]

  • 5. Analyses of potential predictive markers and survival data for a response to sunitinib in patients with metastatic renal cell carcinoma.
    Dornbusch J, Zacharis A, Meinhardt M, Erdmann K, Wolff I, Froehner M, Wirth MP, Zastrow S, Fuessel S.
    PLoS One; 2013 Jul; 8(9):e76386. PubMed ID: 24086736
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Carbonic anhydrase 9 expression increases with vascular endothelial growth factor-targeted therapy and is predictive of outcome in metastatic clear cell renal cancer.
    Stewart GD, O'Mahony FC, Laird A, Rashid S, Martin SA, Eory L, Lubbock AL, Nanda J, O'Donnell M, Mackay A, Mullen P, McNeill SA, Riddick AC, Aitchison M, Berney D, Bex A, Overton IM, Harrison DJ, Powles T.
    Eur Urol; 2014 Nov; 66(5):956-63. PubMed ID: 24821582
    [Abstract] [Full Text] [Related]

  • 8. Carbonic anhydrase IX is associated with early pulmonary spreading of primary colorectal carcinoma and tobacco smoking.
    Schweiger T, Kollmann D, Nikolowsky C, Traxler D, Guenova E, Lang G, Birner P, Klepetko W, Ankersmit HJ, Hoetzenecker K.
    Eur J Cardiothorac Surg; 2014 Jul; 46(1):92-9. PubMed ID: 24321995
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. CA9 gene: single nucleotide polymorphism predicts metastatic renal cell carcinoma prognosis.
    de Martino M, Klatte T, Seligson DB, LaRochelle J, Shuch B, Caliliw R, Li Z, Kabbinavar FF, Pantuck AJ, Belldegrun AS.
    J Urol; 2009 Aug; 182(2):728-34. PubMed ID: 19539328
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. CA9 as a biomarker in preoperative biopsy of small solid renal masses for diagnosis of clear cell renal cell carcinoma.
    Li G, Feng G, Zhao A, Péoc'h M, Cottier M, Mottet N.
    Biomarkers; 2017 Mar; 22(2):123-126. PubMed ID: 27775441
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. MN/CA IX/G250 as a potential target for immunotherapy of renal cell carcinomas.
    Uemura H, Nakagawa Y, Yoshida K, Saga S, Yoshikawa K, Hirao Y, Oosterwijk E.
    Br J Cancer; 1999 Oct; 81(4):741-6. PubMed ID: 10574265
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 19.